Baillie Gifford Valuation
| BGHBX Fund | USD 5.57 0.07 1.27% |
At this time, the entity appears to be fairly valued. Baillie Gifford Health shows a prevailing Real Value of $5.63 per share. The current price of the fund is $5.57. We determine the value of Baillie Gifford Health from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Baillie Gifford's price fluctuation is not too volatile at this time. At this time, the entity appears to be fairly valued. Baillie Gifford Health shows a prevailing Real Value of $5.63 per share. The current price of the fund is $5.57. We determine the value of Baillie Gifford Health from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Baillie Gifford is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Baillie Mutual Fund. However, Baillie Gifford's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.57 | Real 5.63 | Hype 5.57 | Naive 5.39 |
The intrinsic value of Baillie Gifford's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Baillie Gifford's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Baillie Gifford Health helps investors to forecast how Baillie mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Baillie Gifford more accurately as focusing exclusively on Baillie Gifford's fundamentals will not take into account other important factors: About Baillie Gifford Valuation
Our relative valuation model uses a comparative analysis of Baillie Gifford. We calculate exposure to Baillie Gifford's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Baillie Gifford's related companies.The portfolio managers seeks to meet its investment objective by investing primarily in common stocks and other equity securities of companies that the portfolio managers believe have the potential to bring substantial improvements in human health and healthcare systems. Under normal circumstances, the fund invests at least 80 percent of its net assets in equity securities of companies engaged in or supporting innovation in one or more healthcare or healthcare-related industries. The fund is non-diversified.
Other Information on Investing in Baillie Mutual Fund
Baillie Gifford financial ratios help investors to determine whether Baillie Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baillie with respect to the benefits of owning Baillie Gifford security.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |